Showing results (1821-1830 of 2,016) with videos related to
Sort By:
Pageof 202
Lancet (London, England)|February 14, 2012
Inheritance of coronary artery disease in men: an analysis of the role of the Y chromosomeFadi J Charchar, Lisa Ds Bloomer, Timothy A Barnes, et al.The New Phytologist|June 10, 2024
Mycorrhizal associations modify tree diversity-productivity relationships across experimental tree plantationsShan Luo, Bernhard Schmid, Andy Hector, et al.Ecology|May 19, 2024
Tree demographic strategies largely overlap across succession in Neotropical wet and dry forest communitiesMarkus E Schorn, Stephan Kambach, Robin L Chazdon, et al.Molecular Psychiatry|March 11, 2015
Common polygenic risk for autism spectrum disorder (ASD) is associated with cognitive ability in the general populationT-K Clarke, M K Lupton, A M Fernandez-Pujals, et al.Journal for Immunotherapy of Cancer|October 6, 2023
Neoantigen-specific CD4<sup>+</sup> tumor-infiltrating lymphocytes are potent effectors identified within adoptive cell therapy products for metastatic melanoma patientsMacLean S Hall, Jamie K Teer, Xiaoqing Yu, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|March 8, 2025
Regional differences in primary graft dysfunction: A report from the international consortium on PGDJ Guzman-Bofarull, E Ródenas-Alesina, Y Moayedi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 17, 2019
Capivasertib Plus Paclitaxel Versus Placebo Plus Paclitaxel As First-Line Therapy for Metastatic Triple-Negative Breast Cancer: The PAKT TrialPeter Schmid, Jacinta Abraham, Stephen Chan, et al.JAMA Oncology|May 13, 2021
Efficacy of Reduced-Intensity Chemotherapy With Oxaliplatin and Capecitabine on Quality of Life and Cancer Control Among Older and Frail Patients With Advanced Gastroesophageal Cancer: The GO2 Phase 3 Randomized Clinical TrialPeter S Hall, Daniel Swinson, David A Cairns, et al.BMC Cancer|September 21, 2018
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modelingSweet Ping Ng, Houda Bahig, Jihong Wang, et al.Pageof 202